# Portfolio Validation Plan
- K: 1

## Selected Compounds
- 1. index=0 p_act=0.010 kdls=0.213 mw=468.0 logp=4.79

## Quality Summary
- High-confidence (p_actâ‰¥0.7): 0 / 1 (0.0%)
- RO5 compliance: All
- Diversity (mean Tanimoto distance): n/a
- NSGA-II baseline best KDLS: n/a

## Assay Recommendations
- Primary: biochemical/cellular target engagement (IC50/EC50)
- Selectivity: JAK family or class-relevant isoforms
- ADMET: hERG, CYP, solubility, permeability, stability
- Follow-up: microsomes/hepatocytes CLint; route scouting
